Cargando…

Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study

BACKGROUND: Isoniazid resistant tuberculosis is the most prevalent type of resistance in Swaziland and over two-thirds of the isoniazid resistant tuberculosis patients are tuberculosis and human immunodeficiency virus co-infected. The study aimed to determine risk factors associated with isoniazid r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dlamini, Nonhlanhla Christinah, Ji, Dar-Der, Chien, Li-Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701091/ https://www.ncbi.nlm.nih.gov/pubmed/31429717 http://dx.doi.org/10.1186/s12879-019-4384-6

Ejemplares similares

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
por: Sanchez-Padilla, Elisabeth, et al.
Publicado: (2012)

Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland
por: Kujawski, Stephanie A, et al.
Publicado: (2017)

Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi
por: Thindwa, D., et al.
Publicado: (2018)

A national survey of childhood physical abuse among females in Swaziland
por: Breiding, Matthew J., et al.
Publicado: (2013)

Perceived risk of tuberculosis infection among healthcare workers in Swaziland
por: Weng, Yi-Hao, et al.
Publicado: (2016)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Incidence of tuberculosis in human immunodeficiency virus-infected children in India: Is there a role of isoniazid preventive therapy?
por: Shetty, Naman S., et al.
Publicado: (2019)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Public Health Surveillance Strengthening in the Kingdom of Swaziland
por: Sylvester, Joy, et al.
Publicado: (2017)

"Othering" the health worker: self-stigmatization of HIV/AIDS care among health workers in Swaziland
por: de Vries, Daniel H, et al.
Publicado: (2011)

Travel patterns and demographic characteristics of malaria cases in Swaziland, 2010–2014
por: Tejedor‐Garavito, Natalia, et al.
Publicado: (2017)

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

School-based girls' clubs as a means of addressing sexual and gender-based violence in Swaziland
por: Manzini-Henwood, Cebile, et al.
Publicado: (2015)

Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
por: Thai, Phan Vuong Khac, et al.
Publicado: (2018)

Rapid mapping of seasonal malaria transmission risk for strategic elimination planning in Swaziland
por: Cohen, Justin M, et al.
Publicado: (2012)

Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection
por: Xing, Yaru, et al.
Publicado: (2021)

Diabetic retinopathy in Swaziland
por: Burn, Helen, et al.
Publicado: (2015)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Tracking the rate of initiation and retention on isoniazid preventive therapy in a high human immunodeficiency virus and tuberculosis burden setting of Lesotho
por: Mugomeri, Eltony, et al.
Publicado: (2019)

Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia
por: Geremew, Demeke, et al.
Publicado: (2022)

Task shifting or shifting care practices? The impact of task shifting on patients’ experiences and health care arrangements in Swaziland
por: Dlamini-Simelane, Thandeka, et al.
Publicado: (2017)

Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates
por: Dlamini, Sabelo V, et al.
Publicado: (2010)

Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study
por: Mueller, Yolanda, et al.
Publicado: (2017)

Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland
por: Jolly, Pauline E., et al.
Publicado: (2017)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
por: Jenkins, Helen E., et al.
Publicado: (2011)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
por: Stagg, Helen R., et al.
Publicado: (2019)

Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand
por: Charoenpak, Ratchanu, et al.
Publicado: (2020)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
por: Micheni, Lisa Nkatha, et al.
Publicado: (2021)

Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011–2014: A retrospective study
por: Ginindza, Themba G., et al.
Publicado: (2018)

Rapid case-based mapping of seasonal malaria transmission risk for strategic elimination planning in Swaziland
por: Cohen, Justin M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hdhtlvhgrk4ufvmd9ufhfbnf4s